• 1
    Doumith M, Ellington MJ, Livermore DM et al. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009; 63: 659667.
  • 2
    Lartigue MF, Poirel L, Poyart C et al. Ertapenem resistance of Escherichia coli. Emerg Infect Dis 2007; 13: 315317.
  • 3
    Martinez-Martinez L. Extended-spectrum β-lactamases and the permeability barrier. Clin Microbiol Infect 2008; 14 (suppl 1): 8289.
  • 4
    Girlich D, Poirel L, Nordmann P. Do CTX-M β-lactamases hydrolyze carbapenems? J Antimicrob Chemother 2008; 62: 11551156.
  • 5
    Lee EH, Nicolas MH, Kitzis MD et al. Assocation of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high level resistance to imipenem. Antimicrob Agents Chemother 1991; 35: 10931098.
  • 6
    Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 17911798.
  • 7
    Naas T, Nordmann P. Analysis of a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc Natl Acad Sci USA 1994; 91: 76937697.
  • 8
    Baraniak A, Grabowska A, Izdebski R et al. Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008–2009. Antimicrob Agents Chemother 2011; 55: 54935499.
  • 9
    Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228236.
  • 10
    Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol 2011; 19: 588595.
  • 11
    Miriagou V, Cornaglia G, Edelstein E et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010; 16: 112122.
  • 12
    Giske CG, Gezelius L, Samuelsen O et al. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect 2011; 17: 552556.
  • 13
    Miriagou V, Pappagianistis CC, Tzelepi E et al. Detection of VIM-1 production in Proteus mirabilis by an imipenem dipicolinic acid double disk synergy test. J Clin Microbiol 2010; 4: 667668.
  • 14
    Woodford N, Eastaway AT, Ford M et al. Comparison of BD Phoenix,Vitek2 and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae. J Clin Microbiol 2010; 48: 29993002.
  • 15
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI M100-S21. Wayne, PA: CLSI, 2012.
  • 16
    Leclercq R, Cantón R, Brown DFJ et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2011; Oct 21. doi: 10.1111/j.1469-0691.2011.03703.x. [Epub ahead of print].
  • 17
    Vading M, Samuelsen O, Haldorsen B et al. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems. Clin Microbiol Infect 2010; 17: 668674.
  • 18
    Castanheira M, Deshpande LM, Mathai D et al. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrob Agents Chemother 2011; 55: 12741278.
  • 19
    Potron A, Nordmann P, Lafeuille E et al. Characterization of OXA-181, a carbapenem-hydrolyzing class D β-lactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 2011; 55: 48964899.
  • 20
    Mimoz O, Grégoire N, Poirel L et al. Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to a Klebsiella pneumoniae producing the carbapenemase OXA-48. Antimicrob Agents Chemother 2012 (in press).
  • 21
    Centers for Disease Control and Prevention (CDC). Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase—United States. MMWR 2010; 25: 750752.
  • 22
    Seah C, Low DE, Patel SM et al. Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriacae. J Clin Microbiol 2011; 49: 19651969.
  • 23
    Carvalhaes CG, Picao RC, Nicoletti AG et al. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother 2010; 65: 249251.
  • 24
    Lee K, Kim CK, Yong Y et al. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli. J Microb Methods 2010; 83: 149152.
  • 25
    Girlich D, Poirel L, Nordmann P. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriacae. J Clin Microbiol 2012; 50: 477479.
  • 26
    Pasteran FG, Otagegui L, Guerriero L et al. Klebsiella pneumoniae KPC-2 Buenos Aires, Argentina. Emerg Infect Dis 2008; 14: 11781180.
  • 27
    Glupczynski Y, Huang TD, Bouchahrouf W et al. Rapid emergence and spread of OXA-48 producing carbapenem-resistant Enterobacteriacae isolates in Belgian hospitals. Int J Antimicrob Agents 2012; 39: 168178.
  • 28
    Burckhardt I, Zimmermann S. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J Clin Microbiol 2011; 49: 33213324.
  • 29
    Hrabak J, Walkova R, Studentova V et al. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2011; 49: 33273332.
  • 30
    Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011; 70: 119125.
  • 31
    Avlami A, Bekris S, Ganteris G et al. Detection of metallo-β-lactamase genes in clinical specimens by a commercial multiplex PCR system. J Microbiol Methods 2010; 83: 185187.
  • 32
    Chen L, Mediavalla JR, Endimiani A et al. Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (blaKPC) variants. J Clin Microbiol 2011; 49: 579585.
  • 33
    Naas T, Cuzon G, Bogaerts P et al. Evaluation of a DNA microarray (Chcck-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Microbiol 2011; 49: 16081613.
  • 34
    Cohen Stuart J, Leverstein-Van Hall MA, Dutch Working Party on the Detection of Highly Resistant Microorganisms. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 2010; 36: 205210.
  • 35
    Lepelletier D, Andremont A, Grandbastien B et al. Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries; about the French recommendation to limit their spread. J Travel Med 2011; 18: 344351.
  • 36
    Adler A, Navon-Venezia S, Moran-Gilad J et al. Laboratory and clinical evaluation of screening agar plates for the detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol 2011; 49: 22392242.
  • 37
    Landman D, Salvani JK, Bratu S, Quale J. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. J Clin Microbiol 2005; 43: 56395641.
  • 38
    Carrër A, Fortineau N, Nordmann P. Use of ChromID extended-spectrum β-lactamase medium for detecting carbapenemase-producing Enterobacteriaceae. J Clin Microbiol 2010; 48: 19131914.
  • 39
    Nordmann P, Poirel L, Carrër A et al. How to detect NDM-1 producers. J Clin Microbiol 2011; 49: 718723.
  • 40
    Réglier-Poupet H, Naas T, Carrër A et al. Performance of ChromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum β-lactamases. J Med Microbiol 2008; 573: 310315.
  • 41
    Moran-Gilad J, Carmeli Y, Schwartz D et al. Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-non susceptible Enterobacteriaceae. Diagn Microbiol Infect Dis 2011; 70: 565567.
  • 42
    Samra Z, Bahar J, Madar-Shapiro L et al. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 2008; 46: 31103111.
  • 43
    Lolans K, Calvert K, Won S et al. Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens. J Clin Microbiol 2010; 48: 836841.
  • 44
    Ruppé E, Armand-Lefèvre L, Lolom I et al. Development of a phenotypic method for detection of fecal carriage of OXA-48-producing Enterobacteriaceae after incidental detection from clinical specimen. J Clin Microbiol 2011; 49: 27612762.
  • 45
    Nordmann P, Girlich D, Poirel L. Detection of carbapenemase producers in Enterobacteriaceae using a novel screening medium. J Clin Microbiol (in press).
  • 46
    Schechner V, Straus-Robinson K, Schwartz D et al. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of Enterobacteriaceae family. J Clin Microbiol 2009; 47: 32613265.
  • 47
    Naas T, Ergani A, Carrër A et al. Real-time PCR for detection of NDM-1 carbapenemase genes from spiked samples. Antimicrob Agents Chemother 2011; 55: 40384043.